| 000 | 01142 a2200301 4500 | ||
|---|---|---|---|
| 005 | 20250513030543.0 | ||
| 264 | 0 | _c19940106 | |
| 008 | 199401s 0 0 eng d | ||
| 022 | _a0163-4356 | ||
| 024 | 7 |
_a10.1097/00007691-199310000-00010 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aD'Ambrosio, R | |
| 245 | 0 | 0 |
_aValidation and quality assurance program for monitoring tacrolimus (FK 506) concentrations in plasma and whole blood. _h[electronic resource] |
| 260 |
_bTherapeutic drug monitoring _cOct 1993 |
||
| 300 |
_a414-26 p. _bdigital |
||
| 500 | _aPublication Type: Comparative Study; Journal Article; Multicenter Study | ||
| 650 | 0 | 4 | _aBlood Chemical Analysis |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aImmunoenzyme Techniques _xstandards |
| 650 | 0 | 4 |
_aMonitoring, Physiologic _xmethods |
| 650 | 0 | 4 |
_aPlasma _xchemistry |
| 650 | 0 | 4 | _aReproducibility of Results |
| 650 | 0 | 4 |
_aTacrolimus _xblood |
| 700 | 1 | _aGirzaitis, N | |
| 700 | 1 | _aJusko, W J | |
| 773 | 0 |
_tTherapeutic drug monitoring _gvol. 15 _gno. 5 _gp. 414-26 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1097/00007691-199310000-00010 _zAvailable from publisher's website |
| 999 |
_c7503806 _d7503806 |
||